ultragenyx.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Ultragenyx—Treatment of Rare and Ultrarare Genetic
Description For Mason, we go beyond every Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community
Keywords N/A
Server Information
WebSite ultragenyx faviconultragenyx.com
Host IP 138.91.252.236
Location United States
Related Websites
Site Rank
More to Explore
umassathletics.com
unclesandy.com
uncletetsu-ca.com
uncommon.fyi
uncommonbeing.com
uniondayschool.com
unionsquaredonuts.com
unitedbarbell.com
unitedlegalteam.com
unitedstatesglove.com
univasa.com
universalcpareview.com
universeofmarissameyer.com
universitytowersames.com
unmarkedheads.com
unofficialtaylorguitarforum.com
unscear.org
unveiledmarriage.com
up.jobs
updentistryco.com
ultragenyx.com Valuation
US$52,452,589
Last updated: 2023-04-29 08:00:15

ultragenyx.com has Semrush global rank of 201,788. ultragenyx.com has an estimated worth of US$ 52,452,589, based on its estimated Ads revenue. ultragenyx.com receives approximately 6,052,222 unique visitors each day. Its web server is located in United States, with IP address 138.91.252.236. According to SiteAdvisor, ultragenyx.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$52,452,589
Daily Ads Revenue US$48,418
Monthly Ads Revenue US$1,452,534
Yearly Ads Revenue US$17,430,399
Daily Unique Visitors 403,482
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
ultragenyx.com. A 299 IP: 138.91.252.236
ultragenyx.com. NS 86400 NS Record: jose.ns.cloudflare.com.
ultragenyx.com. NS 86400 NS Record: barbara.ns.cloudflare.com.
ultragenyx.com. MX 300 MX Record: 10 mxa-00582201.gslb.pphosted.com.
ultragenyx.com. MX 300 MX Record: 10 mxb-00582201.gslb.pphosted.com.
ultragenyx.com. TXT 300 TXT Record: v=verifydomain MS=6614686
ultragenyx.com. TXT 300 TXT Record: docusign=446d72f8-8332-4793-9047-50bca81dee50
ultragenyx.com. TXT 300 TXT Record: ZOOM_verify_eRttJM-ySImQEs2dcY651w
ultragenyx.com. TXT 300 TXT Record: pardot_77912_*=fb83dcf0cca56c1cd7497cb91eda980b44f7c51801f7cc27ad179229821ce6b0
ultragenyx.com. TXT 300 TXT Record: cisco-ci-domain-verification=3b508f986d47e96fdd2fa1a128789905f8be2156f49b3128cc4e4d50e2d27649
ultragenyx.com. TXT 300 TXT Record: PVPTFLEDqCa1bFjn6Fl0cuozGDFleY/t+HIb4CRIZ/nVZVwe354FOPyTClAmqvxDG3KPm/4gRX4Ej3rF7figVA==
ultragenyx.com. TXT 300 TXT Record: v=spf1 include:%{i}._ip.%{h}._ehlo.%{d}._spf.vali.email include:aspmx.pardot.com ~all
ultragenyx.com. TXT 300 TXT Record: facebook-domain-verification=h1c1xw58j1h21kr9i2a6u07p0u32us
ultragenyx.com. TXT 300 TXT Record: smartsheet-site-validation=oSNb03UlGAnk2oQbeM6xCYfoXU_-7DWl
ultragenyx.com. TXT 300 TXT Record: vosbbh3prg6lh2h596lel16l9j
ultragenyx.com. TXT 300 TXT Record: 4e06e4285239c760c0bef4856f03361bd50c4774
ultragenyx.com. TXT 300 TXT Record: apple-domain-verification=UfHy6W1o23rAUdpI
ultragenyx.com. TXT 300 TXT Record: adobe-idp-site-verification=f47b79f1f541424178ecebee7d07aeb150cc86114324c1786b5662240866fe55
ultragenyx.com. TXT 300 TXT Record: docusign=5c615b68-84a5-42ab-b346-8ac12ee2993d
HtmlToTextCheckTime:2023-04-29 08:00:15
Investors Patient Advocacy U.S. ARGENTINA BRAZIL CANADA (English) CANADA (Français) CHILE COLOMBIA JAPAN MEXICO PERU UNITED STATES Home Ultra-Committed To transform the lives of as many people living with rare diseases as possible, we dedicate ourselves every day to the development and delivery of treatments of rare diseases where none currently exist. Ultra-Committed Learn more Leadership Access to Our Therapies Early Access Model for Corporate Sustainability Grants & Contributions Patient Advocacy Research We develop therapies for rare and ultrarare genetic diseases by exploring an array of drug modalities to select the best treatment strategy for each genetic disease we are studying. Research Learn more Our Science Our Gene Therapy Platform Our Pipeline DTX401 for GSDIa DTX301 for OTC Deficiency UX701 for Wilson Disease UX143 for OI GTX-102 for AS UX053 for GSD III UX111 for MPS IIIA UX055 for CDD Our Clinical Trial Transparency Commitment Medicines Partnerships Join Our Team We
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx/1.14.0 (Ubuntu)
Date: Fri, 22 Oct 2021 07:44:17 GMT
Content-Type: text/html
Content-Length: 194
Connection: keep-alive
Location: https://ultragenyx.com/

HTTP/1.1 301 Moved Permanently
Server: nginx/1.14.0 (Ubuntu)
Date: Fri, 22 Oct 2021 07:44:17 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
X-Redirect-By: WordPress
Location: https://www.ultragenyx.com/

HTTP/1.1 200 OK
Server: nginx/1.14.0 (Ubuntu)
Date: Fri, 22 Oct 2021 07:44:15 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
Link: ; rel="https://api.w.org/"
Link: ; rel="alternate"; type="application/json"
Link: ; rel=shortlink
ultragenyx.com Whois Information
Domain Name: ULTRAGENYX.COM
Registry Domain ID: 1588559037_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.cloudflare.com
Registrar URL: http://www.cloudflare.com
Updated Date: 2021-04-26T04:21:18Z
Creation Date: 2010-03-12T18:52:56Z
Registry Expiry Date: 2027-07-27T11:59:59Z
Registrar: CloudFlare, Inc.
Registrar IANA ID: 1910
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: BARBARA.NS.CLOUDFLARE.COM
Name Server: JOSE.NS.CLOUDFLARE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-10T23:23:17Z <<<